Franklin Q4 Earnings Beat Estimates on Higher Revenues, AUM Rises Y/Y

Franklin Templeton’s fiscal Q4 2026 adjusted EPS was 94 cents, beating the 78-cent estimate; revenue rose 3.9% year over year to $2.43 billion, above the $2.36 billion consensus. AUM increased 8.1% to $1.80 trillion, with $20.8 billion in long-term net inflows versus $11.9 billion in outflows a year earlier, while operating expenses fell 7.9% and operating margin rose to 14.6% from 3.6%. Management expects a roughly 30% adjusted operating margin in fiscal 2027 and raised its fiscal 2029 target to 35%; shareholder servicing and other revenues declined.

Analysis

The useful signal is the contrast in flow momentum, not the EPS beat: Franklin’s positive long-term flows stand against T. Rowe Price’s reported client outflows, potentially giving BEN a relative earnings-revision advantage if flows persist. But one quarter does not establish a durable share-gain trend, and reported AUM can rise with markets even when underlying demand is weak. The near-term earnings quality also needs scrutiny: expense reductions helped, while the cited causes include lower amortization and no repeat impairment charges—less repeatable than recurring cost productivity. Do not compare the quarter’s reported operating margin directly with the fiscal 2027 adjusted-margin target; the accounting bases differ. The guidance implies execution and mix will matter, especially with expense levels projected roughly flat or higher on a flat-market assumption.

Over 1–3 months, watch monthly AUM/flow disclosures, fee-rate stability, and whether management delivers savings without impairing distribution or investment capabilities. Over 6–18 months, alternatives expansion could diversify fee sources, but acquired AUM and commitments do not automatically translate into equivalent recurring fee revenue; integration, fundraising, and fee realization are the tests. A broad market drawdown would pressure AUM-based fees and could overwhelm company-specific flow improvement. The contrarian risk is that investors capitalize a sharp margin recovery as structural even though some comparison-period benefits are nonrecurring and servicing/other revenue remain weak. No valuation data is provided, so the results alone do not establish cheapness or justify a price target.

Key Decisions for Investors

• Consider a measured BEN-versus-TROW relative-value position only after the initial earnings reaction, sized for market-beta exposure; the thesis is relative flow resilience, not a claim that BEN is undervalued. Reassess if subsequent flow reports show BEN’s long-term inflows reversing or TROW’s outflows abating.
• Treat BEN’s fiscal 2027 margin outlook as an execution catalyst, not a realized run rate. Track adjusted expense growth, fee-rate trends, and the reconciliation between reported and adjusted margins; reduce the thesis if costs rise without sustained fee revenue growth.
• Keep Stoneshield and Encina on a watchlist rather than crediting acquisition AUM as immediate earnings growth. Look for disclosed fundraising, fee contribution, integration costs, and realized cost savings over the next several quarters.
• Falsification/risk monitor: a material market decline, renewed net outflows, continued weakness in shareholder-servicing or other revenue, or guidance that moves away from the margin target would undermine the relative-long case. Without valuation and post-earnings price action, avoid adding on the headline beat alone.